Primary Baerveldt versus trabeculectomy study after one‐year follow‐up

Islamaj, Esma; Wubbels, René J.; Waard, Peter W.T. de

doi:10.1111/aos.13658

Cited by 22 publications

(36 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This confirms our expectation from a previous publication that the ophthalmologist should be patient and wait until at least 1 year after surgery before considering any further surgical intervention (Islamaj et al. ). An important difference between the TE and the GDD group of our study was the substantial need for medication in the latter group.…”

Section: Discussionsupporting

confidence: 91%

“…Additional preoperative information on the study patients was presented in an earlier publication (Islamaj et al. ).…”

Section: Resultsmentioning

confidence: 99%

“…The study procedures have been described previously in detail (Islamaj et al. ) In short, we performed a prospective, randomized study at the Rotterdam Eye hospital, the Netherlands, to evaluate two surgical procedures for the treatment of glaucoma. The study was approved by the medical ethical committee of the Erasmus Medical Center (Rotterdam) and is registered at http://www.trialregister.nl (identifier NTR1142).…”

Section: Methodsmentioning

confidence: 99%

“…As the surgical procedures have also been described previously (Islamaj et al. ), only a summary is provided here. Trabeculectomy with MMC superotemporally: the surgeon created a limbus‐based conjunctival flap and applied sponges soaked with MMC (0.2 mg/ml) for 1 min to the sclera.…”

Section: Methodsmentioning

confidence: 99%

“…In a randomized clinical trial, we compared TE and Baerveldt glaucoma implant (BGI) in patients, who never had previous ocular surgery (Islamaj et al. ). Our 1‐year results suggested that, overall when complications and the use of medication into account, TE had a higher success rate than the BGI.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Primary baerveldt versus trabeculectomy study after 5 years of follow‐up

Islamaj

Wubbels

Waard

2019

Acta Ophthalmologica

Self Cite

View full text Add to dashboard Cite

Purpose: Although the Baerveldt glaucoma implant (BGI) initially was reserved for refractory glaucoma, its role in the surgical management of glaucoma has shifted towards a primary treatment choice. We performed a randomized prospective study to compare BGI surgery and trabeculectomy (TE) in patients without previous ocular surgery. Methods: We included 119 glaucoma patients without previous ocular surgery. One eye of each subject was randomized to either a BGI or TE. Follow-up visits were at 1 day, 2 weeks, 6 weeks, 3 months, 6 months and 1, 2, 3, 4 and 5 years postoperatively. Primary outcomes were intraocular pressure (IOP) and failure rate. Secondary outcomes were medication, anterior chamber laser flare value and complications. Results: After 5 years, an IOP of 12.7 AE 3.9 mmHg (mean AE SD) was achieved in the TE group and 12.9 AE 3.9 mmHg in the BGI group. We found no statistically significant difference in failure rate between the groups (p = 0.72). More BGI patients needed additional medication to control their IOP (85%; 1.9 AE 1.2 types of glaucoma medication) compared to the TE patients (57%; 0.5 AE 0.9 types of glaucoma medication). Diplopia was significantly more present in the BGI group than in the TE group (27% versus 4%; p < 0.001). The self-limiting complication rate was similar in both groups. Conclusions: Our study demonstrates that, in the long term, the final IOP and failure rate are similar after TE and BGI surgery. However, the need for additional medication after BGI surgery is higher than after TE. Also, the increased risk of developing diplopia after BGI surgery must be taken into consideration.

show abstract

Section: Discussionsupporting

confidence: 91%

“…Additional preoperative information on the study patients was presented in an earlier publication (Islamaj et al. ).…”

Section: Resultsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%